Title | Cardiovascular Drugs and Therapy |
Abbreviation | Cardiovasc. Drugs Ther. |
Publication Type | Journal |
Subject Area, Categories, Scope | Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1) |
h-index | 75 |
Overall Rank/Ranking | 4882 |
SCImago Journal Rank (SJR) | 0.913 |
Impact Score | 3.59 |
Publisher | Kluwer Academic Publishers |
Country | Netherlands |
ISSN | 15737241, 09203206 |
Best Quartile | Q1 |
Coverage History | 1987-2022 |
Cardiovascular Drugs and Therapy is a journal covering the technologies/fields/categories related to Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1). It is published by Kluwer Academic Publishers. The overall rank of Cardiovascular Drugs and Therapy is 4882. According to SCImago Journal Rank (SJR), this journal is ranked 0.913. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 75. The best quartile for this journal is Q1.
The ISSN of Cardiovascular Drugs and Therapy journal is 15737241, 09203206. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cardiovascular Drugs and Therapy is cited by a total of 1023 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Cardiovascular Drugs and Therapy is 3.59, which is computed in 2023 as per its definition. Cardiovascular Drugs and Therapy IF is increased by a factor of 0.26 and approximate percentage change is 7.81% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Cardiovascular Drugs and Therapy is 3.59. If the same upward trend persists, Impact IF may rise in 2023 as well.
Year | Impact IF |
---|---|
2023/2024 | Coming Soon |
2022 | 3.59 |
2021 | 3.33 |
2020 | 2.83 |
2019 | 3.65 |
2018 | 3.91 |
2017 | 2.66 |
2016 | 2.54 |
2015 | 2.82 |
2014 | 2.82 |
Cardiovascular Drugs and Therapy has an h-index of 75. It means 75 articles of this journal have more than 75 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Cardiovascular Drugs and Therapy is 15737241, 09203206. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Cardiovascular Drugs and Therapy is 4882. According to SCImago Journal Rank (SJR), this journal is ranked 0.913. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Year | SJR |
---|---|
2023/2024 | Coming Soon |
2022 | 0.913 |
2021 | 0.860 |
2020 | 1.108 |
2019 | 1.360 |
2018 | 1.338 |
2017 | 1.349 |
2016 | 1.067 |
2015 | 1.238 |
2014 | 1.222 |
Year | Ranking |
---|---|
2023/2024 | Coming Soon |
2022 | 4882 |
2021 | 5141 |
2020 | 3748 |
2019 | 2641 |
2018 | 2737 |
2017 | 2749 |
2016 | 4008 |
2015 | 3248 |
2014 | 3231 |
Cardiovascular Drugs and Therapy is published by Kluwer Academic Publishers. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 1987-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Cardiovascular Drugs and Therapy is Cardiovasc. Drugs Ther.. This abbreviation ('Cardiovasc. Drugs Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Cardiovascular Drugs and Therapy latest impact IF is 3.59. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 3.91 (2018) and 2.54 (2016), respectively, in the last 9 years. Moreover, its average IS is 3.13 in the previous 9 years.
The Cardiovascular Drugs and Therapy has an SJR (SCImago Journal Rank) of 0.913, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.360 in 2019 and the lowest being 0.860 in 2021. Furthermore, the average SJR of the Cardiovascular Drugs and Therapy over the previous 9-year period stands at 3.13.
The latest h-index of the Cardiovascular Drugs and Therapy is 75.
The Cardiovascular Drugs and Therapy is published by the Kluwer Academic Publishers, with its country of publication being the Netherlands.
The Cardiovascular Drugs and Therapy is currently ranked 4882 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 2641 in 2019 and its lowest position of 5141 in 2021.
The standard ISO4 abbreviation for the Cardiovascular Drugs and Therapy is Cardiovasc. Drugs Ther..
Cardiovascular Drugs and Therapy is classified as a journal that the Kluwer Academic Publishers publishes.
The Cardiovascular Drugs and Therapy encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Cardiovascular Drugs and Therapy is assigned the following International Standard Serial Numbers (ISSN): 15737241, 09203206.
The best quartile for the Cardiovascular Drugs and Therapy is Q1 (2022).
The Cardiovascular Drugs and Therapy coverage history can be summarized as follows: 1987-2022.
Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
---|---|---|---|---|---|
Indian Journal of Plastic Surgery | journal | 16018 | Thieme Medical Publishers Inc. | 37 | 0.65 |
Historia | journal | 27560 | Universidade Estadual Paulista | 7 | 0.02 |
Entrepreneurship Theory and Practice | journal | 338 | Wiley-Blackwell | 185 | 12.75 |
International Journal of Mathematical Education in Science and Technology | journal | 10040 | Taylor and Francis Ltd. | 39 | 1.33 |
Air and Space Power Journal (discontinued) | journal | 28397 | AU Press | 9 | 0.20 |
Marine Biology Research | journal | 13573 | Taylor and Francis Ltd. | 42 | 1.06 |
Tekstilec | trade journal | 19217 | Faculty of Natural Sciences and Engineering, Tekstilec | 14 | 0.73 |
Population Review | journal | 17841 | Sociological Demography Press | 13 | 0.73 |
Rudarsko Geolosko Naftni Zbornik | journal | 14294 | University of Zagreb, Faculty of Mining, Geology and Petroleum Engineering | 17 | 1.48 |
Transboundary and Emerging Diseases | journal | 4279 | Wiley-Blackwell Publishing Ltd | 78 | 4.95 |
Year | Impact Score (IS) |
---|---|
2023/2024 | Coming Soon |
2022 | 3.59 |
2021 | 3.33 |
2020 | 2.83 |
2019 | 3.65 |
2018 | 3.91 |
2017 | 2.66 |
2016 | 2.54 |
2015 | 2.82 |
2014 | 2.82 |